Display options
Cite
Graier T, Golob-Schwarzl N, Weger W, et al. Furin Expression in Patients With Psoriasis-A Patient Cohort Endangered to SARS-COV2?. Front Med (Lausanne). 2021;8:624462doi: 10.3389/fmed.2021.624462.
Graier, T., Golob-Schwarzl, N., Weger, W., Benezeder, T., Painsi, C., Salmhofer, W., & Wolf, P. (2021). Furin Expression in Patients With Psoriasis-A Patient Cohort Endangered to SARS-COV2?. Frontiers in medicine, 8624462. https://doi.org/10.3389/fmed.2021.624462
Graier, Thomas, et al. "Furin Expression in Patients With Psoriasis-A Patient Cohort Endangered to SARS-COV2?." Frontiers in medicine vol. 8 (2021): 624462. doi: https://doi.org/10.3389/fmed.2021.624462
Graier T, Golob-Schwarzl N, Weger W, Benezeder T, Painsi C, Salmhofer W, Wolf P. Furin Expression in Patients With Psoriasis-A Patient Cohort Endangered to SARS-COV2?. Front Med (Lausanne). 2021 Feb 10;8:624462. doi: 10.3389/fmed.2021.624462. eCollection 2021. PMID: 33644099; PMCID: PMC7902756.
Copy Download .nbib Format: NLM
Share it on

Front Med (Lausanne). 2021 Feb 10;8:624462. doi: 10.3389/fmed.2021.624462. eCollection 2021.

Furin Expression in Patients With Psoriasis-A Patient Cohort Endangered to SARS-COV2?.

Frontiers in medicine

Thomas Graier, Nicole Golob-Schwarzl, Wolfgang Weger, Theresa Benezeder, Clemens Painsi, Wolfgang Salmhofer, Peter Wolf

Affiliations

  1. Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
  2. Department of Dermatology and Venereology, State Hospital, Klagenfurt, Austria.

PMID: 33644099 PMCID: PMC7902756 DOI: 10.3389/fmed.2021.624462

[No abstract available.]

Copyright © 2021 Graier, Golob-Schwarzl, Weger, Benezeder, Painsi, Salmhofer and Wolf.

Keywords: COVID-19; SARS-CoV-2; angiotensin converting enzyme-2; furin; psoriasis; psoriatic arthritis; secukinumab; ustekinumab

Conflict of interest statement

PW has received research grants, speaker and/or consulting honoraria, and/or travel refunds from AbbVie, Amgen GmbH, Almirall, Celgene, Eli Lilly, Janssen, Leo Pharma, Novartis, Merck Sharp & Dohme, S

References

  1. Med Hypotheses. 2020 Oct;143:109893 - PubMed
  2. Cell. 2020 Apr 16;181(2):281-292.e6 - PubMed
  3. Br J Dermatol. 2020 Aug;183(2):373-374 - PubMed
  4. Atherosclerosis. 2011 Dec;219(2):799-806 - PubMed
  5. PLoS One. 2013 Aug 06;8(8):e70542 - PubMed
  6. Dermatol Ther. 2020 Nov;33(6):e14516 - PubMed
  7. Nature. 2008 Sep 11;455(7210):246-50 - PubMed
  8. J Invest Dermatol. 2018 Aug;138(8):1726-1735 - PubMed
  9. Am J Physiol Heart Circ Physiol. 2020 May 1;318(5):H1080-H1083 - PubMed
  10. J Immunol. 2018 Nov 1;201(9):2612-2623 - PubMed
  11. Intern Emerg Med. 2020 Nov;15(8):1477-1484 - PubMed
  12. Mol Biol Rep. 2020 Jun;47(6):4383-4392 - PubMed
  13. Scand J Immunol. 2015 Dec;82(6):539-46 - PubMed
  14. J Intern Med. 2018 Oct;284(4):377-387 - PubMed
  15. Lancet Gastroenterol Hepatol. 2020 May;5(5):425-427 - PubMed
  16. Front Immunol. 2020 Jan 15;10:3096 - PubMed
  17. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e676-e679 - PubMed
  18. Lancet. 2020 Mar 28;395(10229):1054-1062 - PubMed
  19. J Leukoc Biol. 2015 Jul;98(1):73-83 - PubMed
  20. Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L1020-L1022 - PubMed
  21. Oncotarget. 2016 Aug 23;7(34):54392-54404 - PubMed
  22. Eur Heart J. 2014 Nov 14;35(43):3001-3 - PubMed
  23. Blood. 2006 Aug 1;108(3):983-5 - PubMed
  24. Biomed Res Int. 2015;2015:148651 - PubMed
  25. Dermatol Ther. 2020 Sep;33(5):e13687 - PubMed
  26. Dermatol Ther. 2020 Jul;33(4):e13298 - PubMed
  27. Dermatol Ther. 2020 Jul;33(4):e13434 - PubMed
  28. Allergy. 2020 Nov;75(11):2829-2845 - PubMed
  29. Curr Biol. 2020 Apr 6;30(7):1346-1351.e2 - PubMed
  30. J Biol Chem. 2007 Jul 20;282(29):20847-53 - PubMed
  31. Viruses. 2020 Apr 10;12(4): - PubMed
  32. Scand J Rheumatol. 2019 May;48(3):173-177 - PubMed
  33. Lancet. 2020 Feb 15;395(10223):497-506 - PubMed
  34. Br J Dermatol. 2021 Jan;184(1):78-86 - PubMed
  35. Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):47-50 - PubMed
  36. Front Immunol. 2020 May 01;11:827 - PubMed
  37. EMBO J. 2020 May 18;39(10):e105114 - PubMed
  38. Ann Rheum Dis. 2020 Jul;79(7):859-866 - PubMed
  39. J Infect Dis. 2016 Mar 15;213(6):904-14 - PubMed
  40. J Biol Chem. 2012 Jun 22;287(26):21992-2003 - PubMed
  41. Adv Clin Chem. 2013;61:1-31 - PubMed
  42. Lancet Respir Med. 2020 Apr;8(4):e21 - PubMed
  43. Pharmacol Rev. 2017 Jan;69(1):33-52 - PubMed
  44. Lancet. 2020 Mar 28;395(10229):1033-1034 - PubMed
  45. Infect Dis Poverty. 2020 Apr 28;9(1):45 - PubMed
  46. J Invest Dermatol. 2019 May;139(5):1054-1062 - PubMed
  47. Dermatol Ther. 2020 Nov;33(6):e13858 - PubMed
  48. Expert Opin Biol Ther. 2021 Feb;21(2):271-277 - PubMed
  49. J Proteome Res. 2016 Jul 1;15(7):2102-14 - PubMed
  50. J Allergy Clin Immunol. 2021 Feb;147(2):558-560.e1 - PubMed
  51. Elife. 2020 Jun 02;9: - PubMed
  52. Diabetes Care. 2020 Jul;43(7):1416-1426 - PubMed
  53. J Am Acad Dermatol. 2020 May;82(5):1217-1218 - PubMed
  54. Mol Cell Endocrinol. 2020 Sep 15;515:110917 - PubMed

Publication Types